TAKARA BIO INC.
4974・Prime Market・Chemicals
Governance
Company with a Board of Corporate Auditors. The Board of Directors consists of 9 members, including 3 outside directors (outside director ratio of 33.3%), with 100% attendance by all members at Board meetings. The company has established a voluntary Nomination and Compensation Committee chaired by an independent outside director, as well as a Special Committee aimed at protecting minority shareholders. The executive officer system separates supervision from business execution.
Risk Management
The TAKARA BIO Compliance Committee, chaired by the President, oversees overall risk management, working in coordination with the Risk and Compliance Committee of the parent company, Takara Holdings Inc. An independent internal audit department has been established based on internal audit regulations, working closely with the Audit & Supervisory Board Members. In the event of an emergency, a framework has been put in place to establish an emergency response headquarters based on the business continuity plan. Regarding sustainability risks, eight materiality issues have been identified, with regular reporting to the Sustainability Promotion Committee and the Board of Directors.
Shareholder Returns
For FY2026 (ending March 2026), the company recorded a net loss attributable to owners of the parent of ¥9,599 million, resulting in no annual dividend (¥0). This represents a drop to no dividend from the FY2025 (ended March 2025) year-end dividend of ¥17. Due to the planned delisting following the successful tender offer by TAKARA HOLDINGS INC., no dividend forecast for FY2027 (ending March 2027) has been disclosed.
Dividend Policy
For FY2026 (ending March 2026), due to the net loss recorded, the annual dividend is ¥0 (no dividend). For FY2025 (ended March 2025), a year-end dividend of ¥17.00 per share was paid (total dividends of ¥2,047 million, payout ratio of 196.5%), but no dividend will be paid for the current fiscal year. As the tender offer by TAKARA HOLDINGS INC. has been completed and the company is scheduled to become a wholly owned subsidiary and be delisted (planned for June 12, 2026) following the required procedures, no dividend forecast for FY2027 (ending March 2027) is disclosed.
ESG
Conducted climate change scenario analysis (below 2°C and 4°C scenarios) based on the TCFD framework, targeting a 50% reduction in CO2 emissions intensity by FY2025 compared to FY2018 levels, but the FY2024 actual result remained at 86% of the FY2018 level. In human capital initiatives, the company is promoting diversity and work-style reform, including an increase in female managers (11 newly appointed), a disabled employment rate of 3.0% (exceeding the statutory rate of 2.5%), a male childcare leave uptake rate of 75.0%, and acquisition of Kurumin and Eruboshi certifications. The Sustainability Promotion Committee, chaired by the President and Executive Officer, plans, executes, and evaluates activities under the oversight of the Board of Directors.
Last updated: June 20, 2025